Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers July 17, 2018
Pharmacy Choice - News - Pharmaceutical Industry Trends and Policy - July 17, 2018

Pharmacy News

 Pharmaceutical Industry Trends and Policy
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

7/17/18 - Allergy Immunotherapy Market Blatant Growth with USD 4,324.7 million | with Foremost Players like Allergy Therapeutics, Circassia, DBV Technologies, etc. by 2023 Says MRFR
Along with this regional analysis of the market which includes America, Europe, Asia Pacific and Middle East and Africa.. The market is expected to grow at the CAGR of~ 10.85% during the forecast period and is estimated to reach USD 4,324.7 million by 2023.. Some of the key players in this market are: ALK Abello A/S, Allergy Therapeutics, Circassia
7/17/18 - American College of Rheumatology on Trump's Drug Pricing Blueprint: Reforms Must Protect Patient Access to Biologic Therapies
The American College of Rheumatology issued the following news release:. In its comment letter responding to the Department of Health and Human Services' Request for Information on the Trump Administration's American Patient's First drug pricing blueprint, the American College of Rheumatology urged policymakers to protect patient access to drugs...
7/17/18 - U.S. Approves New Drug To Treat Smallpox To Counter Risk Of Bio-Terrorism [Daily Independent (Nigeria)]
The U.S. Food and Drug Administration has approved the new drug tecovirimat to treat smallpox, the first drug against the deadly disease since a huge vaccination campaign over three decades ago. To address the risk of bio-terrorism, Congress has taken steps to enable the development and approval of countermeasures to thwart pathogens that
7/16/18 - "Dosage Form Comprising an Active Ingredient and a Plurality of Solid Porous Microcarriers" in Patent Application Approval Process (USPTO 20180177806)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor Yamamoto, Akira, filed on February 26, 2018, was made available online on July 5, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institution
7/16/18 - "Hair Removal Compositions and Methods" in Patent Application Approval Process (USPTO 20180177700)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor ROTUNDA, ADAM M., filed on December 28, 2016, was made available online on July 5, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent application has not been assigned to a company or institutio
7/16/18 - "Pharmaceutical Compositions" in Patent Application Approval Process (USPTO 20180177719)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Jones, Alan; Rodriguez, Cesar; Henzler, David; Currington, Jeff; Sharma, Megha; Aldrich, Daniel; Currington, Cameron; Sloane, Michael, filed on February 21, 2016, was made available online on July 5, 2018, according to news reporting originating fro
7/16/18 - "Raman Spectroscopic Structure Investigation of Proteins Dispersed in a Liquid Phase" in Patent Application Approval Process (USPTO 20180180549)
By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventor Lewis, E. Neil, filed on March 25, 2015, was made available online on July 5, 2018, according to news reporting originating from Washington, D.C., by NewsRx correspondents. The following quote was obtained by the news editors from the background info
7/16/18 - 2018 and Beyond: Canada Pharmaceutical & Healthcare Market Trends & Outlook Study to 2025
Spending on medicines and healthcare in Canada witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/expansion opportunities. This report focuses its attention on pharmaceutical market in Canada and presents market trends, drivers and challenges facing the R&D...
7/16/18 - 2018 and Beyond: Canada Pharmaceutical & Healthcare Market Trends & Outlook Study to 2025 - ResearchAndMarkets.com
Spending on medicines and healthcare in Canada witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/expansion opportunities. This report focuses its attention on pharmaceutical market in Canada and presents market trends, drivers and challenges facing the R&D...
7/16/18 - 2018 and Beyond: Ireland Pharmaceutical & Healthcare Market Trends & Outlook Study to 2025
Spending on medicines and healthcare in Ireland witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/expansion opportunities. This report focuses its attention on pharmaceutical market in Ireland and presents market trends, drivers and challenges facing the R&D...
7/16/18 - 2018 and Beyond: Ireland Pharmaceutical & Healthcare Market Trends & Outlook Study to 2025 - ResearchAndMarkets.com
Spending on medicines and healthcare in Ireland witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/expansion opportunities. This report focuses its attention on pharmaceutical market in Ireland and presents market trends, drivers and challenges facing the R&D...
7/16/18 - 2018 and Beyond: Spain Pharmaceutical & Healthcare Market Trends & Outlook Study to 2025
Spending on medicines and healthcare in Spain witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/expansion opportunities. This report focuses its attention on pharmaceutical market in Spain and presents market trends, drivers and challenges facing the R&D professionals,..
7/16/18 - 2018 and Beyond: United Kingdom Pharmaceutical & Healthcare Market Trends & Outlook Study to 2025
Spending on medicines and healthcare in United Kingdom witnessed steady growth in 2017, reflecting strong potential for new medicine development, infrastructure building and new entry/ expansion opportunities. This report focuses its attention on pharmaceutical market in United Kingdom and presents market trends, drivers and challenges facing the..
7/16/18 - 2018 Innovations in Simulation, Visualization, and Analytical Tools for Drug Development Processes - ResearchAndMarkets.com
By a News Reporter-Staff News Editor at Clinical Trials Week The "Innovations in Simulation, Visualization, and Analytical Tools for Drug Development Processes" report has been added to ResearchAndMarkets.com' s offering. This Drug Discovery TOE provides insights across in vivo, in vitro, and in silico assay technologies enabling enhanced drug di
7/16/18 - 2018 Novel Therapies for Rare and Genetic Diseases: Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy
The "Novel Therapies for Rare and Genetic Diseases" report has been added to ResearchAndMarkets.com' s offering. Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and
7/16/18 - 2018 Novel Therapies for Rare and Genetic Diseases: Unveiling One of the Most Promising Fields of Therapeutic Technology Synergy - ResearchAndMarkets.com
The "Novel Therapies for Rare and Genetic Diseases" report has been added to ResearchAndMarkets.com' s offering. Recent advancement in the development of novel platforms of smart targeting small molecules, gene therapy, stem cell therapy, gene modification, and gene rectification technologies pose new prospects for therapies and cures for rare and
7/16/18 - 21 Stocks Moving In Monday's Pre-Market Session
Gainers Tonix Pharmaceuticals Holding Corp. rose 29.2 percent to $5.10 in pre-market trading after the company disclosed that it has received Fast Track designation from the U.S. FDA for TNX-102 SL for the treatment of agitation in Alzheimer's disease. Coda Octopus Group, Inc. rose 26 percent to $4.71 in pre-market trading after the company disclos
7/16/18 - A reliable source for Valsartan medicines
A Recall Alert was issued by the Drug Regulatory Authority of Pakistan on July 12th, 2018 in response to a letter by EMA with reference to the subject of carcinogenic impurities found in Valsartan raw materials manufactured by M/S Zhejiang Huahai Pharmaceutical Co. Ltd, China. According to the Journal of Pakistan Medical Association and National He
7/16/18 - Abbott Laboratories Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (Jul. 3, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Abbott Laboratories was posted on July 3, 2018. The SEC file number is 0001179110-18-009367.. A U.S. Securities and Exchange Commission filing is a f
7/16/18 - AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax
NORTH CHICAGO- AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid...
7/16/18 - ABPI - Pharmaceutical industry reaction to Brexit White Paper
The White Paper contains references to topics of particular importance to the pharmaceutical industry including: Manufactured goods: The Paper recognises the importance of the UK keeping supply chains operating efficiently to the benefit of patients through application of a common rulebook for medicines and through the UK being an active participan
7/16/18 - ABPI response to European Medicines Agency survey
Ensuring there is no disruption for both UK and EU patients from day one of Brexit remains our top priority. By the time the UK leaves the EU, companies will have spent hundreds of millions on complex contingency plans covering all possible scenarios. Our message remains the same- with 45 million packs of medicines leaving the UK for Europe and 37
7/16/18 - Acceleron Receives FDA Orphan Drug Designation for ACE-083 in Facioscapulohumeral Muscular Dystrophy
CAMBRIDGE- Acceleron Pharma Inc., a leading biopharmaceutical company in the discovery and development of TGF-beta therapeutics to treat serious and rare diseases, today announced that the United States Food and Drug Administration has granted orphan drug designation for ACE-083, the Company's locally acting' Myostatin+' muscle agent, for the treat
7/16/18 - Acelrx Pharmaceuticals Inc. Files SEC Form 8-K, Current Report: (Jul. 2, 2018)
By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission filing by Acelrx Pharmaceuticals Inc. was posted on July 2, 2018. The SEC file number is 0001437749-18-012799.. A U.S. Securities and Exchange Commission filin
7/16/18 - Acron Medical Announces FDA 510(k) Clearance of its Signature PEEK TLIF Interbody System, the ACRON Interbody.
Acron Medical, LLC, part of the spineMED Group, is a spine technology organization, dedicated to developing and commercializing globally innovative spinal implants. The company is proud to announce that it has received 510 clearance from the FDA for its signature new technology, the ACRON TLIF Interbody system. Andreas Bernegger, Acron Medical's Co
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415